Theracann and iCAN align to better support global cannabis technology adoption
|
HONG KONG, Nov. 1, 2018 /PRNewswire/ -- iCAN: israel-cannabis is pleased to announce the signing of a bilateral service agreement and strategic alliance with Theracann International Benchmark Corporation to assist in promoting the Company's many incubated technologies and cannabis services globally. Theracann a technology, operations and analytics company with operations in North American, Oceania and South America provides regulatory services and advanced technology to the cannabis industry. The agreement will allow iCAN to deliver Theracann's technology to emerging markets in Europe, Africa and Asia while allowing Theracann clients and projects access to iCAN's deep technology pipeline and expertise. "I'm excited to put Theracann's ETCH (Electronic Traceability for Cannabis and Hemp) biotrace technology in front of the Israeli government," says Saul Kaye, Founder and CEO of iCAN. "The ability to use DNA to tag and trace cannabis at any point of the supply chain is the gold standard of diversion and IP control." iCAN is a technology incubator and service provider based in Israel, known globally for their CannaTech conferences dedicated to accelerating cannabis innovation. iCAN was formed to build a global cannabis eco-system, connecting stakeholders from all aspects of the industry. "The CannaTech conferences are unique in that they bring innovators from all sectors intent on creating lasting connections and relationships," says Jason Warnock, CEO of Theracann International. "The iCAN accelerator portfolio companies represent a wealth of innovation for our operational footprint and clients in markets around the world. We are very excited about the opportunity to be aligned with such a key global partner." About iCAN: Israel-Cannabis About CannaTech About TheraCann International Benchmark Corporation More information about TheraCann is available at www.theracanncorp.com. Follow us on Twitter or Linkedin For further information about iCAN, please visit www.israel-cannabis.com or contact: Laura Kam, laura@kamgs.com +972-54-806-8613
SOURCE iCAN: Israel-Cannabis; TheraCann International Benchmark Corporation |